Castuner

Oncology Learning Network

HMP Global

Podcast by HMP Global

Site do podcast

Ouça no seu app

Episódios

191 episódios

  1. Artificial Intelligence Advances Lymphoma Diagnosis, Biomarker Identification, and Precision Treatment 5:17
  2. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice 10:57
  3. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice 12:28
  4. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice 13:58
  5. Preparing for Biomarker-Directed Care in epNEC: What Pathologists Need to Know Now 12:28
  6. Artificial Intelligence for Skin Cancer Diagnosis 11:57
  7. Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF 17:10
  8. Real-World Decision Points in Biomarker-Driven NSCLC Management 5:17
  9. Connecting the Dots: How MET Fits Into Comprehensive Molecular Profiling 3:56
  10. Testing Matters: Practical Approaches to Biomarker Evaluation in NSCLC 6:47
  11. Tafasitamab Plus Lenalidomide Improves Frontline Outcomes in High-Risk Diffuse Large B-Cell Lymphoma 6:30
  12. When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma 8:50
  13. Closing the Gap Between CAR T–Cell Therapy Recognition and Referral in Multiple Myeloma 13:03
  14. Olverembatinib Plus Blinatumomab Produces Deep Responses in Ph+ Acute Lymphoblastic Leukemia 3:44
  15. How is ctDNA MRD Testing Used in Lymphoma Care? 9:11
  16. How Are We Detecting Residual Disease in Lymphoma Today? 8:48
  17. How Are We Detecting Residual Disease in Lymphoma Today? 8:59
  18. Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG) 8:55
  19. Navigating The Complexity of Melanoma Care: Part 6 2:01
  20. Navigating The Complexity of Melanoma Care: Part 5 1:35
  21. Navigating The Complexity of Melanoma Care: Part 4 2:40
  22. Navigating The Complexity of Melanoma Care: Part 3 1:15
  23. Navigating The Complexity of Melanoma Care: Part 2 2:16
  24. Navigating The Complexity of Melanoma Care: Part 1 2:46
  25. Community Education Program Improves Patient Education and Cancer Screening Rates 7:01
  26. Cholangioscopy: What Interventional Oncologists Need to Know Part 2 46:05
  27. Cholangioscopy: What Interventional Oncologists Need to Know 41:01
  28. Applications of AR in Interventional Oncology 11:45
  29. How Artificial Intelligence May Change Interventional Oncology 26:30
  30. Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial 7:31
  31. Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia 26:10
  32. Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer 7:17
  33. Advances in Gastrointestinal Genetic Testing 4:51
  34. Enfortumab Vedotin for Metastatic Urothelial Cancer After Progression on Platinum-Based Chemotherapy 6:58
  35. BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma 7:33
  36. Durvalumab Conveys Benefit for All Biliary Tract Cancer Types 5:29
  37. Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements 4:32
  38. Maintenance Cabozantinib in Metastatic Urothelial Carcinoma 4:51
  39. Sacituzumab Govitecan Plus Pembrolizumab for Platinum-Refractory Metastatic Urothelial Cancer 8:45
  40. Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer 7:06
  41. Part 1: Current Emerging Therapies for Platinum-Resistant Ovarian Malignancies With Dr O'Mally 9:48
  42. Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML 25:00
  43. Ibrutinib Improves Outcomes Over Rituximab Among Patients With Advanced CLL/SLL 8:40
  44. Evolving Roles of KRAS Inhibitors in CRC 1:45
  45. The Role of Tumor Mutation Burden Featuring Dr Morris 0:50
  46. Dr Morris Discusses Emerging Targeted Therapies in mCRC 3:02
  47. Dr Lieu Talks ctDNA to Guide CRC Treatment 3:15
  48. Dr Casulo Overviews Approved Treatment Options to Manage Newly Diagnosed, Relapsed FL 5:20
  49. Dr Batlevi Shares Promising Data of Tazemetostat from SYMPHONY-1 Trial 4:46
  50. Dr Loprinzi Reviews Hot Flash Treatment Strategies in BC, Part II 0:19